ixekizumab,guselkumab,secukinumab
novartis,janssen,eli lilly
['tremfya', 'derm', 'taltz', 'cosentyx', 'janssen']
#aad2023- #janssen presented the new data of #tremfya demonstrating persistent efficacy versus #cosentyx and #taltz across the broad patient population. #pharma #pharmaceutical #healthcare #globalhealth #news #media #aad23 #aad #conferences #dermatology
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma